nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRM5—telencephalic ventricle—germ cell cancer	0.0344	0.0744	CbGeAlD
Acamprosate—GRIN1—telencephalic ventricle—germ cell cancer	0.0217	0.047	CbGeAlD
Acamprosate—GRM5—ganglion—germ cell cancer	0.0214	0.0463	CbGeAlD
Acamprosate—GRIN2B—telencephalic ventricle—germ cell cancer	0.0207	0.0448	CbGeAlD
Acamprosate—GRIN1—ganglion—germ cell cancer	0.0135	0.0292	CbGeAlD
Acamprosate—GRIN2B—ganglion—germ cell cancer	0.0129	0.0279	CbGeAlD
Acamprosate—GRIN2A—ganglion—germ cell cancer	0.0113	0.0244	CbGeAlD
Acamprosate—GRM5—brainstem—germ cell cancer	0.00932	0.0201	CbGeAlD
Acamprosate—GRM5—telencephalon—germ cell cancer	0.00827	0.0179	CbGeAlD
Acamprosate—GRIN3B—testis—germ cell cancer	0.00789	0.017	CbGeAlD
Acamprosate—GRIN2C—brainstem—germ cell cancer	0.0071	0.0153	CbGeAlD
Acamprosate—GRIN2D—brainstem—germ cell cancer	0.0066	0.0143	CbGeAlD
Acamprosate—GRIN2C—telencephalon—germ cell cancer	0.0063	0.0136	CbGeAlD
Acamprosate—GRM5—midbrain—germ cell cancer	0.00594	0.0128	CbGeAlD
Acamprosate—GRIN1—brainstem—germ cell cancer	0.00588	0.0127	CbGeAlD
Acamprosate—GRIN2D—telencephalon—germ cell cancer	0.00586	0.0127	CbGeAlD
Acamprosate—GRM5—spinal cord—germ cell cancer	0.0058	0.0125	CbGeAlD
Acamprosate—GRIN2B—brainstem—germ cell cancer	0.00561	0.0121	CbGeAlD
Acamprosate—GRIN3A—telencephalon—germ cell cancer	0.00551	0.0119	CbGeAlD
Acamprosate—GRIN1—telencephalon—germ cell cancer	0.00522	0.0113	CbGeAlD
Acamprosate—GRM5—endocrine gland—germ cell cancer	0.00522	0.0113	CbGeAlD
Acamprosate—GRM5—head—germ cell cancer	0.00515	0.0111	CbGeAlD
Acamprosate—GRIN2B—telencephalon—germ cell cancer	0.00498	0.0108	CbGeAlD
Acamprosate—GRM5—testis—germ cell cancer	0.00498	0.0107	CbGeAlD
Acamprosate—GRIN2C—medulla oblongata—germ cell cancer	0.00495	0.0107	CbGeAlD
Acamprosate—GRIN2A—brainstem—germ cell cancer	0.00491	0.0106	CbGeAlD
Acamprosate—SLC36A1—brainstem—germ cell cancer	0.00488	0.0105	CbGeAlD
Acamprosate—GRIN2D—medulla oblongata—germ cell cancer	0.0046	0.00994	CbGeAlD
Acamprosate—GRM5—cerebellum—germ cell cancer	0.0046	0.00992	CbGeAlD
Acamprosate—GRIN2A—telencephalon—germ cell cancer	0.00435	0.0094	CbGeAlD
Acamprosate—SLC36A1—telencephalon—germ cell cancer	0.00433	0.00934	CbGeAlD
Acamprosate—GRIN2D—spinal cord—germ cell cancer	0.0041	0.00887	CbGeAlD
Acamprosate—GRIN2C—head—germ cell cancer	0.00392	0.00848	CbGeAlD
Acamprosate—GRIN2C—testis—germ cell cancer	0.00379	0.00819	CbGeAlD
Acamprosate—GRIN1—midbrain—germ cell cancer	0.00375	0.0081	CbGeAlD
Acamprosate—GRM5—brain—germ cell cancer	0.00373	0.00806	CbGeAlD
Acamprosate—GRIN1—spinal cord—germ cell cancer	0.00366	0.0079	CbGeAlD
Acamprosate—GRIN2D—head—germ cell cancer	0.00365	0.00788	CbGeAlD
Acamprosate—SLC36A1—gonad—germ cell cancer	0.00361	0.0078	CbGeAlD
Acamprosate—SLC36A1—uterus—germ cell cancer	0.00359	0.00775	CbGeAlD
Acamprosate—GRIN2D—testis—germ cell cancer	0.00352	0.00761	CbGeAlD
Acamprosate—GRIN2C—cerebellum—germ cell cancer	0.0035	0.00756	CbGeAlD
Acamprosate—GABRG2—trigeminal ganglion—germ cell cancer	0.00349	0.00754	CbGeAlD
Acamprosate—GRIN2B—spinal cord—germ cell cancer	0.00349	0.00754	CbGeAlD
Acamprosate—GRIN3A—head—germ cell cancer	0.00343	0.00741	CbGeAlD
Acamprosate—GRIN2A—medulla oblongata—germ cell cancer	0.00342	0.00739	CbGeAlD
Acamprosate—GRIN3A—testis—germ cell cancer	0.00331	0.00716	CbGeAlD
Acamprosate—GRIN1—endocrine gland—germ cell cancer	0.00329	0.00711	CbGeAlD
Acamprosate—GRIN2D—cerebellum—germ cell cancer	0.00325	0.00703	CbGeAlD
Acamprosate—GRIN1—head—germ cell cancer	0.00325	0.00702	CbGeAlD
Acamprosate—GRIN2A—adrenal gland—germ cell cancer	0.00317	0.00684	CbGeAlD
Acamprosate—SLC36A1—adrenal gland—germ cell cancer	0.00315	0.0068	CbGeAlD
Acamprosate—GRIN2B—endocrine gland—germ cell cancer	0.00314	0.00679	CbGeAlD
Acamprosate—GRIN2A—midbrain—germ cell cancer	0.00313	0.00675	CbGeAlD
Acamprosate—GRIN2B—head—germ cell cancer	0.0031	0.0067	CbGeAlD
Acamprosate—GRIN2A—spinal cord—germ cell cancer	0.00305	0.00659	CbGeAlD
Acamprosate—SLC36A1—bone marrow—germ cell cancer	0.00304	0.00658	CbGeAlD
Acamprosate—SLC36A1—female gonad—germ cell cancer	0.00293	0.00634	CbGeAlD
Acamprosate—GRIN1—cerebellum—germ cell cancer	0.0029	0.00627	CbGeAlD
Acamprosate—GRIN2C—brain—germ cell cancer	0.00284	0.00614	CbGeAlD
Acamprosate—GRIN2B—cerebellum—germ cell cancer	0.00277	0.00598	CbGeAlD
Acamprosate—GRIN2A—endocrine gland—germ cell cancer	0.00275	0.00593	CbGeAlD
Acamprosate—GABRG2—telencephalon—germ cell cancer	0.00274	0.00592	CbGeAlD
Acamprosate—SLC36A1—endocrine gland—germ cell cancer	0.00273	0.00589	CbGeAlD
Acamprosate—GABRA1—brainstem—germ cell cancer	0.00273	0.00589	CbGeAlD
Acamprosate—GRIN2A—head—germ cell cancer	0.00271	0.00586	CbGeAlD
Acamprosate—SLC36A1—head—germ cell cancer	0.00269	0.00582	CbGeAlD
Acamprosate—GABRB3—trigeminal ganglion—germ cell cancer	0.00268	0.00579	CbGeAlD
Acamprosate—GRIN2D—brain—germ cell cancer	0.00264	0.00571	CbGeAlD
Acamprosate—GRIN2A—testis—germ cell cancer	0.00262	0.00566	CbGeAlD
Acamprosate—SLC36A1—testis—germ cell cancer	0.0026	0.00562	CbGeAlD
Acamprosate—GRIN3A—brain—germ cell cancer	0.00249	0.00537	CbGeAlD
Acamprosate—GABRA1—telencephalon—germ cell cancer	0.00242	0.00523	CbGeAlD
Acamprosate—GRIN2A—cerebellum—germ cell cancer	0.00242	0.00522	CbGeAlD
Acamprosate—SLC36A1—cerebellum—germ cell cancer	0.0024	0.00519	CbGeAlD
Acamprosate—GRIN1—brain—germ cell cancer	0.00236	0.00509	CbGeAlD
Acamprosate—GABRB3—eye—germ cell cancer	0.00231	0.00499	CbGeAlD
Acamprosate—GRIN2B—brain—germ cell cancer	0.00225	0.00485	CbGeAlD
Acamprosate—GABRG2—pituitary gland—germ cell cancer	0.00223	0.00482	CbGeAlD
Acamprosate—GABRG2—medulla oblongata—germ cell cancer	0.00216	0.00465	CbGeAlD
Acamprosate—GABRB3—telencephalon—germ cell cancer	0.00211	0.00455	CbGeAlD
Acamprosate—GABRG2—midbrain—germ cell cancer	0.00197	0.00425	CbGeAlD
Acamprosate—GRIN2A—brain—germ cell cancer	0.00196	0.00424	CbGeAlD
Acamprosate—SLC36A1—brain—germ cell cancer	0.00195	0.00422	CbGeAlD
Acamprosate—GABRG2—spinal cord—germ cell cancer	0.00192	0.00415	CbGeAlD
Acamprosate—GABRA1—medulla oblongata—germ cell cancer	0.0019	0.00411	CbGeAlD
Acamprosate—SLC36A1—lymph node—germ cell cancer	0.00189	0.00407	CbGeAlD
Acamprosate—GABRB3—gonad—germ cell cancer	0.00176	0.0038	CbGeAlD
Acamprosate—GABRA1—midbrain—germ cell cancer	0.00174	0.00376	CbGeAlD
Acamprosate—GABRB3—pituitary gland—germ cell cancer	0.00172	0.0037	CbGeAlD
Acamprosate—GABRG2—head—germ cell cancer	0.00171	0.00369	CbGeAlD
Acamprosate—GABRA1—spinal cord—germ cell cancer	0.0017	0.00366	CbGeAlD
Acamprosate—GABRB3—medulla oblongata—germ cell cancer	0.00166	0.00357	CbGeAlD
Acamprosate—GABRG2—cerebellum—germ cell cancer	0.00152	0.00329	CbGeAlD
Acamprosate—GABRB3—midbrain—germ cell cancer	0.00151	0.00327	CbGeAlD
Acamprosate—GABRA1—head—germ cell cancer	0.00151	0.00326	CbGeAlD
Acamprosate—GABRB3—spinal cord—germ cell cancer	0.00148	0.00319	CbGeAlD
Acamprosate—GABRA1—cerebellum—germ cell cancer	0.00135	0.00291	CbGeAlD
Acamprosate—GABRB3—endocrine gland—germ cell cancer	0.00133	0.00287	CbGeAlD
Acamprosate—GABRB3—head—germ cell cancer	0.00131	0.00283	CbGeAlD
Acamprosate—GABRB3—testis—germ cell cancer	0.00127	0.00274	CbGeAlD
Acamprosate—GABRG2—brain—germ cell cancer	0.00124	0.00267	CbGeAlD
Acamprosate—GABRB3—cerebellum—germ cell cancer	0.00117	0.00253	CbGeAlD
Acamprosate—Lymphadenopathy—Methotrexate—germ cell cancer	0.00111	0.00217	CcSEcCtD
Acamprosate—Agitation—Ifosfamide—germ cell cancer	0.00111	0.00216	CcSEcCtD
Acamprosate—Discomfort—Dactinomycin—germ cell cancer	0.0011	0.00216	CcSEcCtD
Acamprosate—Angioedema—Ifosfamide—germ cell cancer	0.0011	0.00215	CcSEcCtD
Acamprosate—Anorexia—Bleomycin—germ cell cancer	0.0011	0.00214	CcSEcCtD
Acamprosate—GABRA1—brain—germ cell cancer	0.00109	0.00236	CbGeAlD
Acamprosate—Thrombophlebitis—Methotrexate—germ cell cancer	0.00109	0.00214	CcSEcCtD
Acamprosate—Diabetes mellitus—Methotrexate—germ cell cancer	0.00109	0.00213	CcSEcCtD
Acamprosate—Hypoaesthesia—Etoposide—germ cell cancer	0.00109	0.00213	CcSEcCtD
Acamprosate—Malaise—Ifosfamide—germ cell cancer	0.00109	0.00212	CcSEcCtD
Acamprosate—Vertigo—Ifosfamide—germ cell cancer	0.00108	0.00212	CcSEcCtD
Acamprosate—Leukopenia—Ifosfamide—germ cell cancer	0.00108	0.00211	CcSEcCtD
Acamprosate—Polyuria—Methotrexate—germ cell cancer	0.00108	0.00211	CcSEcCtD
Acamprosate—Immune system disorder—Cisplatin—germ cell cancer	0.00108	0.00211	CcSEcCtD
Acamprosate—Abdominal pain—Vinblastine—germ cell cancer	0.00108	0.00211	CcSEcCtD
Acamprosate—Hypotension—Bleomycin—germ cell cancer	0.00107	0.0021	CcSEcCtD
Acamprosate—Infection—Dactinomycin—germ cell cancer	0.00106	0.00208	CcSEcCtD
Acamprosate—Palpitations—Ifosfamide—germ cell cancer	0.00106	0.00208	CcSEcCtD
Acamprosate—Alopecia—Cisplatin—germ cell cancer	0.00105	0.00206	CcSEcCtD
Acamprosate—Cough—Ifosfamide—germ cell cancer	0.00105	0.00206	CcSEcCtD
Acamprosate—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00105	0.00205	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00105	0.00205	CcSEcCtD
Acamprosate—Convulsion—Ifosfamide—germ cell cancer	0.00104	0.00204	CcSEcCtD
Acamprosate—Hypertension—Ifosfamide—germ cell cancer	0.00104	0.00203	CcSEcCtD
Acamprosate—Malnutrition—Cisplatin—germ cell cancer	0.00104	0.00203	CcSEcCtD
Acamprosate—Paraesthesia—Bleomycin—germ cell cancer	0.00103	0.00202	CcSEcCtD
Acamprosate—Dyspnoea—Bleomycin—germ cell cancer	0.00102	0.00201	CcSEcCtD
Acamprosate—Arthralgia—Ifosfamide—germ cell cancer	0.00102	0.00201	CcSEcCtD
Acamprosate—Myalgia—Ifosfamide—germ cell cancer	0.00102	0.00201	CcSEcCtD
Acamprosate—Chest pain—Ifosfamide—germ cell cancer	0.00102	0.00201	CcSEcCtD
Acamprosate—Renal failure acute—Methotrexate—germ cell cancer	0.00102	0.002	CcSEcCtD
Acamprosate—Flatulence—Cisplatin—germ cell cancer	0.00102	0.002	CcSEcCtD
Acamprosate—Anorexia—Dactinomycin—germ cell cancer	0.00102	0.002	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00102	0.00199	CcSEcCtD
Acamprosate—Discomfort—Ifosfamide—germ cell cancer	0.00101	0.00198	CcSEcCtD
Acamprosate—Hypersensitivity—Vinblastine—germ cell cancer	0.001	0.00196	CcSEcCtD
Acamprosate—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.001	0.00196	CcSEcCtD
Acamprosate—Decreased appetite—Bleomycin—germ cell cancer	0.000999	0.00196	CcSEcCtD
Acamprosate—Muscle spasms—Cisplatin—germ cell cancer	0.000997	0.00195	CcSEcCtD
Acamprosate—Confusional state—Ifosfamide—germ cell cancer	0.00099	0.00194	CcSEcCtD
Acamprosate—Immune system disorder—Etoposide—germ cell cancer	0.000986	0.00193	CcSEcCtD
Acamprosate—Pain—Bleomycin—germ cell cancer	0.000983	0.00192	CcSEcCtD
Acamprosate—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000982	0.00192	CcSEcCtD
Acamprosate—Chills—Etoposide—germ cell cancer	0.00098	0.00192	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000976	0.00191	CcSEcCtD
Acamprosate—Asthenia—Vinblastine—germ cell cancer	0.000976	0.00191	CcSEcCtD
Acamprosate—Infection—Ifosfamide—germ cell cancer	0.000976	0.00191	CcSEcCtD
Acamprosate—Tremor—Cisplatin—germ cell cancer	0.000972	0.0019	CcSEcCtD
Acamprosate—Alopecia—Etoposide—germ cell cancer	0.000965	0.00189	CcSEcCtD
Acamprosate—Ill-defined disorder—Cisplatin—germ cell cancer	0.000962	0.00188	CcSEcCtD
Acamprosate—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000961	0.00188	CcSEcCtD
Acamprosate—Anaemia—Cisplatin—germ cell cancer	0.000959	0.00188	CcSEcCtD
Acamprosate—Skin disorder—Ifosfamide—germ cell cancer	0.000954	0.00187	CcSEcCtD
Acamprosate—GABRB3—brain—germ cell cancer	0.000951	0.00205	CbGeAlD
Acamprosate—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000949	0.00186	CcSEcCtD
Acamprosate—Feeling abnormal—Bleomycin—germ cell cancer	0.000947	0.00185	CcSEcCtD
Acamprosate—Anorexia—Ifosfamide—germ cell cancer	0.000936	0.00183	CcSEcCtD
Acamprosate—Malaise—Cisplatin—germ cell cancer	0.000935	0.00183	CcSEcCtD
Acamprosate—Decreased appetite—Dactinomycin—germ cell cancer	0.000932	0.00182	CcSEcCtD
Acamprosate—Diarrhoea—Vinblastine—germ cell cancer	0.000931	0.00182	CcSEcCtD
Acamprosate—Dysgeusia—Etoposide—germ cell cancer	0.000931	0.00182	CcSEcCtD
Acamprosate—Leukopenia—Cisplatin—germ cell cancer	0.000929	0.00182	CcSEcCtD
Acamprosate—Back pain—Etoposide—germ cell cancer	0.000919	0.0018	CcSEcCtD
Acamprosate—Hypotension—Ifosfamide—germ cell cancer	0.000918	0.0018	CcSEcCtD
Acamprosate—Pain—Dactinomycin—germ cell cancer	0.000916	0.00179	CcSEcCtD
Acamprosate—Muscle spasms—Etoposide—germ cell cancer	0.000914	0.00179	CcSEcCtD
Acamprosate—Urticaria—Bleomycin—germ cell cancer	0.000913	0.00179	CcSEcCtD
Acamprosate—Body temperature increased—Bleomycin—germ cell cancer	0.000908	0.00178	CcSEcCtD
Acamprosate—Dizziness—Vinblastine—germ cell cancer	0.0009	0.00176	CcSEcCtD
Acamprosate—Convulsion—Cisplatin—germ cell cancer	0.000899	0.00176	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000895	0.00175	CcSEcCtD
Acamprosate—Myalgia—Cisplatin—germ cell cancer	0.000883	0.00173	CcSEcCtD
Acamprosate—Feeling abnormal—Dactinomycin—germ cell cancer	0.000883	0.00173	CcSEcCtD
Acamprosate—Paraesthesia—Ifosfamide—germ cell cancer	0.000882	0.00173	CcSEcCtD
Acamprosate—Ill-defined disorder—Etoposide—germ cell cancer	0.000882	0.00173	CcSEcCtD
Acamprosate—Anxiety—Cisplatin—germ cell cancer	0.00088	0.00172	CcSEcCtD
Acamprosate—Anaemia—Etoposide—germ cell cancer	0.000878	0.00172	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000877	0.00172	CcSEcCtD
Acamprosate—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000876	0.00172	CcSEcCtD
Acamprosate—Dyspnoea—Ifosfamide—germ cell cancer	0.000875	0.00171	CcSEcCtD
Acamprosate—Somnolence—Ifosfamide—germ cell cancer	0.000873	0.00171	CcSEcCtD
Acamprosate—Liver function test abnormal—Methotrexate—germ cell cancer	0.000873	0.00171	CcSEcCtD
Acamprosate—Discomfort—Cisplatin—germ cell cancer	0.000873	0.00171	CcSEcCtD
Acamprosate—Vomiting—Vinblastine—germ cell cancer	0.000865	0.00169	CcSEcCtD
Acamprosate—Malaise—Etoposide—germ cell cancer	0.000857	0.00168	CcSEcCtD
Acamprosate—Breast disorder—Methotrexate—germ cell cancer	0.000854	0.00167	CcSEcCtD
Acamprosate—Vertigo—Etoposide—germ cell cancer	0.000854	0.00167	CcSEcCtD
Acamprosate—Decreased appetite—Ifosfamide—germ cell cancer	0.000854	0.00167	CcSEcCtD
Acamprosate—Headache—Vinblastine—germ cell cancer	0.000852	0.00167	CcSEcCtD
Acamprosate—Leukopenia—Etoposide—germ cell cancer	0.000851	0.00167	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000848	0.00166	CcSEcCtD
Acamprosate—Abdominal pain—Dactinomycin—germ cell cancer	0.000847	0.00166	CcSEcCtD
Acamprosate—Body temperature increased—Dactinomycin—germ cell cancer	0.000847	0.00166	CcSEcCtD
Acamprosate—Anaphylactic shock—Cisplatin—germ cell cancer	0.000847	0.00166	CcSEcCtD
Acamprosate—Hypersensitivity—Bleomycin—germ cell cancer	0.000847	0.00166	CcSEcCtD
Acamprosate—Infection—Cisplatin—germ cell cancer	0.000841	0.00165	CcSEcCtD
Acamprosate—Constipation—Ifosfamide—germ cell cancer	0.00084	0.00164	CcSEcCtD
Acamprosate—Pain—Ifosfamide—germ cell cancer	0.00084	0.00164	CcSEcCtD
Acamprosate—Loss of consciousness—Etoposide—germ cell cancer	0.000835	0.00164	CcSEcCtD
Acamprosate—Cough—Etoposide—germ cell cancer	0.000829	0.00162	CcSEcCtD
Acamprosate—Thrombocytopenia—Cisplatin—germ cell cancer	0.000829	0.00162	CcSEcCtD
Acamprosate—Tachycardia—Cisplatin—germ cell cancer	0.000826	0.00162	CcSEcCtD
Acamprosate—Asthenia—Bleomycin—germ cell cancer	0.000824	0.00161	CcSEcCtD
Acamprosate—Convulsion—Etoposide—germ cell cancer	0.000823	0.00161	CcSEcCtD
Acamprosate—Skin disorder—Cisplatin—germ cell cancer	0.000822	0.00161	CcSEcCtD
Acamprosate—Hypertension—Etoposide—germ cell cancer	0.00082	0.00161	CcSEcCtD
Acamprosate—Hyperhidrosis—Cisplatin—germ cell cancer	0.000818	0.0016	CcSEcCtD
Acamprosate—Asthma—Methotrexate—germ cell cancer	0.000817	0.0016	CcSEcCtD
Acamprosate—Pruritus—Bleomycin—germ cell cancer	0.000813	0.00159	CcSEcCtD
Acamprosate—Feeling abnormal—Ifosfamide—germ cell cancer	0.000809	0.00158	CcSEcCtD
Acamprosate—Chest pain—Etoposide—germ cell cancer	0.000809	0.00158	CcSEcCtD
Acamprosate—Eosinophilia—Methotrexate—germ cell cancer	0.000809	0.00158	CcSEcCtD
Acamprosate—Nausea—Vinblastine—germ cell cancer	0.000808	0.00158	CcSEcCtD
Acamprosate—Anorexia—Cisplatin—germ cell cancer	0.000807	0.00158	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000803	0.00157	CcSEcCtD
Acamprosate—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000803	0.00157	CcSEcCtD
Acamprosate—Pancreatitis—Methotrexate—germ cell cancer	0.000801	0.00157	CcSEcCtD
Acamprosate—Discomfort—Etoposide—germ cell cancer	0.000799	0.00156	CcSEcCtD
Acamprosate—Hypotension—Cisplatin—germ cell cancer	0.000791	0.00155	CcSEcCtD
Acamprosate—Hypersensitivity—Dactinomycin—germ cell cancer	0.00079	0.00155	CcSEcCtD
Acamprosate—Confusional state—Etoposide—germ cell cancer	0.000782	0.00153	CcSEcCtD
Acamprosate—Urticaria—Ifosfamide—germ cell cancer	0.00078	0.00153	CcSEcCtD
Acamprosate—Body temperature increased—Ifosfamide—germ cell cancer	0.000776	0.00152	CcSEcCtD
Acamprosate—Abdominal pain—Ifosfamide—germ cell cancer	0.000776	0.00152	CcSEcCtD
Acamprosate—Anaphylactic shock—Etoposide—germ cell cancer	0.000776	0.00152	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000771	0.00151	CcSEcCtD
Acamprosate—Infection—Etoposide—germ cell cancer	0.000771	0.00151	CcSEcCtD
Acamprosate—Asthenia—Dactinomycin—germ cell cancer	0.000769	0.00151	CcSEcCtD
Acamprosate—Paraesthesia—Cisplatin—germ cell cancer	0.00076	0.00149	CcSEcCtD
Acamprosate—Thrombocytopenia—Etoposide—germ cell cancer	0.000759	0.00149	CcSEcCtD
Acamprosate—Tachycardia—Etoposide—germ cell cancer	0.000757	0.00148	CcSEcCtD
Acamprosate—Dyspnoea—Cisplatin—germ cell cancer	0.000755	0.00148	CcSEcCtD
Acamprosate—Skin disorder—Etoposide—germ cell cancer	0.000753	0.00147	CcSEcCtD
Acamprosate—Erectile dysfunction—Methotrexate—germ cell cancer	0.000752	0.00147	CcSEcCtD
Acamprosate—Hyperhidrosis—Etoposide—germ cell cancer	0.00075	0.00147	CcSEcCtD
Acamprosate—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000746	0.00146	CcSEcCtD
Acamprosate—Anorexia—Etoposide—germ cell cancer	0.000739	0.00145	CcSEcCtD
Acamprosate—Decreased appetite—Cisplatin—germ cell cancer	0.000736	0.00144	CcSEcCtD
Acamprosate—Diarrhoea—Dactinomycin—germ cell cancer	0.000733	0.00144	CcSEcCtD
Acamprosate—Pneumonia—Methotrexate—germ cell cancer	0.000733	0.00143	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000731	0.00143	CcSEcCtD
Acamprosate—Vomiting—Bleomycin—germ cell cancer	0.000731	0.00143	CcSEcCtD
Acamprosate—Depression—Methotrexate—germ cell cancer	0.000726	0.00142	CcSEcCtD
Acamprosate—Hypotension—Etoposide—germ cell cancer	0.000725	0.00142	CcSEcCtD
Acamprosate—Rash—Bleomycin—germ cell cancer	0.000724	0.00142	CcSEcCtD
Acamprosate—Pain—Cisplatin—germ cell cancer	0.000724	0.00142	CcSEcCtD
Acamprosate—Dermatitis—Bleomycin—germ cell cancer	0.000724	0.00142	CcSEcCtD
Acamprosate—Hypersensitivity—Ifosfamide—germ cell cancer	0.000724	0.00142	CcSEcCtD
Acamprosate—Stomatitis—Methotrexate—germ cell cancer	0.00071	0.00139	CcSEcCtD
Acamprosate—GRIN1—Mecp2 and Associated Rett Syndrome—FGF4—germ cell cancer	0.000706	0.027	CbGpPWpGaD
Acamprosate—Asthenia—Ifosfamide—germ cell cancer	0.000705	0.00138	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000702	0.0268	CbGpPWpGaD
Acamprosate—Sweating—Methotrexate—germ cell cancer	0.000698	0.00137	CcSEcCtD
Acamprosate—Feeling abnormal—Cisplatin—germ cell cancer	0.000698	0.00137	CcSEcCtD
Acamprosate—Paraesthesia—Etoposide—germ cell cancer	0.000696	0.00136	CcSEcCtD
Acamprosate—Pruritus—Ifosfamide—germ cell cancer	0.000695	0.00136	CcSEcCtD
Acamprosate—Haematuria—Methotrexate—germ cell cancer	0.000695	0.00136	CcSEcCtD
Acamprosate—Dyspnoea—Etoposide—germ cell cancer	0.000691	0.00135	CcSEcCtD
Acamprosate—Somnolence—Etoposide—germ cell cancer	0.00069	0.00135	CcSEcCtD
Acamprosate—Epistaxis—Methotrexate—germ cell cancer	0.000687	0.00135	CcSEcCtD
Acamprosate—Nausea—Bleomycin—germ cell cancer	0.000683	0.00134	CcSEcCtD
Acamprosate—Vomiting—Dactinomycin—germ cell cancer	0.000681	0.00133	CcSEcCtD
Acamprosate—Rash—Dactinomycin—germ cell cancer	0.000676	0.00132	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000675	0.0258	CbGpPWpGaD
Acamprosate—Decreased appetite—Etoposide—germ cell cancer	0.000674	0.00132	CcSEcCtD
Acamprosate—Diarrhoea—Ifosfamide—germ cell cancer	0.000672	0.00132	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00067	0.00131	CcSEcCtD
Acamprosate—Body temperature increased—Cisplatin—germ cell cancer	0.000669	0.00131	CcSEcCtD
Acamprosate—Constipation—Etoposide—germ cell cancer	0.000663	0.0013	CcSEcCtD
Acamprosate—Pain—Etoposide—germ cell cancer	0.000663	0.0013	CcSEcCtD
Acamprosate—Haemoglobin—Methotrexate—germ cell cancer	0.000657	0.00129	CcSEcCtD
Acamprosate—GRM5—G alpha (q) signalling events—OXT—germ cell cancer	0.000654	0.025	CbGpPWpGaD
Acamprosate—Haemorrhage—Methotrexate—germ cell cancer	0.000654	0.00128	CcSEcCtD
Acamprosate—Hepatitis—Methotrexate—germ cell cancer	0.000654	0.00128	CcSEcCtD
Acamprosate—Dizziness—Ifosfamide—germ cell cancer	0.000649	0.00127	CcSEcCtD
Acamprosate—Pharyngitis—Methotrexate—germ cell cancer	0.000649	0.00127	CcSEcCtD
Acamprosate—Feeling abnormal—Etoposide—germ cell cancer	0.000639	0.00125	CcSEcCtD
Acamprosate—Nausea—Dactinomycin—germ cell cancer	0.000637	0.00125	CcSEcCtD
Acamprosate—Gastrointestinal pain—Etoposide—germ cell cancer	0.000634	0.00124	CcSEcCtD
Acamprosate—Visual impairment—Methotrexate—germ cell cancer	0.00063	0.00123	CcSEcCtD
Acamprosate—Vomiting—Ifosfamide—germ cell cancer	0.000624	0.00122	CcSEcCtD
Acamprosate—Hypersensitivity—Cisplatin—germ cell cancer	0.000624	0.00122	CcSEcCtD
Acamprosate—Rash—Ifosfamide—germ cell cancer	0.000619	0.00121	CcSEcCtD
Acamprosate—Dermatitis—Ifosfamide—germ cell cancer	0.000619	0.00121	CcSEcCtD
Acamprosate—Urticaria—Etoposide—germ cell cancer	0.000616	0.00121	CcSEcCtD
Acamprosate—Abdominal pain—Etoposide—germ cell cancer	0.000613	0.0012	CcSEcCtD
Acamprosate—Body temperature increased—Etoposide—germ cell cancer	0.000613	0.0012	CcSEcCtD
Acamprosate—Tinnitus—Methotrexate—germ cell cancer	0.00061	0.00119	CcSEcCtD
Acamprosate—Asthenia—Cisplatin—germ cell cancer	0.000607	0.00119	CcSEcCtD
Acamprosate—Immune system disorder—Methotrexate—germ cell cancer	0.000591	0.00116	CcSEcCtD
Acamprosate—Chills—Methotrexate—germ cell cancer	0.000587	0.00115	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.000585	0.0224	CbGpPWpGaD
Acamprosate—Nausea—Ifosfamide—germ cell cancer	0.000583	0.00114	CcSEcCtD
Acamprosate—Diarrhoea—Cisplatin—germ cell cancer	0.000579	0.00113	CcSEcCtD
Acamprosate—Alopecia—Methotrexate—germ cell cancer	0.000578	0.00113	CcSEcCtD
Acamprosate—Mental disorder—Methotrexate—germ cell cancer	0.000573	0.00112	CcSEcCtD
Acamprosate—Hypersensitivity—Etoposide—germ cell cancer	0.000571	0.00112	CcSEcCtD
Acamprosate—Malnutrition—Methotrexate—germ cell cancer	0.000569	0.00111	CcSEcCtD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000566	0.0216	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000558	0.0213	CbGpPWpGaD
Acamprosate—Dysgeusia—Methotrexate—germ cell cancer	0.000557	0.00109	CcSEcCtD
Acamprosate—Asthenia—Etoposide—germ cell cancer	0.000556	0.00109	CcSEcCtD
Acamprosate—Back pain—Methotrexate—germ cell cancer	0.000551	0.00108	CcSEcCtD
Acamprosate—Pruritus—Etoposide—germ cell cancer	0.000549	0.00107	CcSEcCtD
Acamprosate—GRIN2C—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—germ cell cancer	0.000539	0.0206	CbGpPWpGaD
Acamprosate—Vomiting—Cisplatin—germ cell cancer	0.000538	0.00105	CcSEcCtD
Acamprosate—Rash—Cisplatin—germ cell cancer	0.000534	0.00104	CcSEcCtD
Acamprosate—Dermatitis—Cisplatin—germ cell cancer	0.000533	0.00104	CcSEcCtD
Acamprosate—Diarrhoea—Etoposide—germ cell cancer	0.000531	0.00104	CcSEcCtD
Acamprosate—Ill-defined disorder—Methotrexate—germ cell cancer	0.000528	0.00103	CcSEcCtD
Acamprosate—Anaemia—Methotrexate—germ cell cancer	0.000526	0.00103	CcSEcCtD
Acamprosate—Malaise—Methotrexate—germ cell cancer	0.000513	0.001	CcSEcCtD
Acamprosate—Dizziness—Etoposide—germ cell cancer	0.000513	0.001	CcSEcCtD
Acamprosate—Vertigo—Methotrexate—germ cell cancer	0.000511	0.001	CcSEcCtD
Acamprosate—Leukopenia—Methotrexate—germ cell cancer	0.00051	0.000997	CcSEcCtD
Acamprosate—Nausea—Cisplatin—germ cell cancer	0.000503	0.000984	CcSEcCtD
Acamprosate—GRIN2D—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—germ cell cancer	0.000501	0.0192	CbGpPWpGaD
Acamprosate—Cough—Methotrexate—germ cell cancer	0.000497	0.000972	CcSEcCtD
Acamprosate—Convulsion—Methotrexate—germ cell cancer	0.000493	0.000966	CcSEcCtD
Acamprosate—Vomiting—Etoposide—germ cell cancer	0.000493	0.000965	CcSEcCtD
Acamprosate—Rash—Etoposide—germ cell cancer	0.000489	0.000957	CcSEcCtD
Acamprosate—Dermatitis—Etoposide—germ cell cancer	0.000489	0.000956	CcSEcCtD
Acamprosate—Headache—Etoposide—germ cell cancer	0.000486	0.000951	CcSEcCtD
Acamprosate—Myalgia—Methotrexate—germ cell cancer	0.000485	0.000949	CcSEcCtD
Acamprosate—Chest pain—Methotrexate—germ cell cancer	0.000485	0.000949	CcSEcCtD
Acamprosate—Arthralgia—Methotrexate—germ cell cancer	0.000485	0.000949	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000481	0.000942	CcSEcCtD
Acamprosate—Discomfort—Methotrexate—germ cell cancer	0.000479	0.000937	CcSEcCtD
Acamprosate—GABRB3—Ion channel transport—SCNN1A—germ cell cancer	0.000468	0.0179	CbGpPWpGaD
Acamprosate—Confusional state—Methotrexate—germ cell cancer	0.000468	0.000917	CcSEcCtD
Acamprosate—Anaphylactic shock—Methotrexate—germ cell cancer	0.000465	0.000909	CcSEcCtD
Acamprosate—Infection—Methotrexate—germ cell cancer	0.000462	0.000904	CcSEcCtD
Acamprosate—Nausea—Etoposide—germ cell cancer	0.000461	0.000902	CcSEcCtD
Acamprosate—GABRG2—Ion channel transport—SCNN1A—germ cell cancer	0.00046	0.0176	CbGpPWpGaD
Acamprosate—Thrombocytopenia—Methotrexate—germ cell cancer	0.000455	0.00089	CcSEcCtD
Acamprosate—Skin disorder—Methotrexate—germ cell cancer	0.000451	0.000883	CcSEcCtD
Acamprosate—Hyperhidrosis—Methotrexate—germ cell cancer	0.000449	0.000879	CcSEcCtD
Acamprosate—GRM5—G alpha (q) signalling events—AVP—germ cell cancer	0.000448	0.0171	CbGpPWpGaD
Acamprosate—Anorexia—Methotrexate—germ cell cancer	0.000443	0.000867	CcSEcCtD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00044	0.0168	CbGpPWpGaD
Acamprosate—Hypotension—Methotrexate—germ cell cancer	0.000434	0.00085	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000423	0.000829	CcSEcCtD
Acamprosate—Insomnia—Methotrexate—germ cell cancer	0.00042	0.000823	CcSEcCtD
Acamprosate—Paraesthesia—Methotrexate—germ cell cancer	0.000417	0.000817	CcSEcCtD
Acamprosate—Dyspnoea—Methotrexate—germ cell cancer	0.000414	0.000811	CcSEcCtD
Acamprosate—Somnolence—Methotrexate—germ cell cancer	0.000413	0.000809	CcSEcCtD
Acamprosate—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—germ cell cancer	0.000412	0.0157	CbGpPWpGaD
Acamprosate—Dyspepsia—Methotrexate—germ cell cancer	0.000409	0.000801	CcSEcCtD
Acamprosate—Decreased appetite—Methotrexate—germ cell cancer	0.000404	0.000791	CcSEcCtD
Acamprosate—GABRA1—Ion channel transport—SCNN1A—germ cell cancer	0.000402	0.0154	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.000401	0.0153	CbGpPWpGaD
Acamprosate—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000401	0.000785	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000397	0.0152	CbGpPWpGaD
Acamprosate—Pain—Methotrexate—germ cell cancer	0.000397	0.000778	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—ALPL—germ cell cancer	0.000387	0.0148	CbGpPWpGaD
Acamprosate—GRIN2C—CREB phosphorylation through the activation of Ras—HRAS—germ cell cancer	0.000384	0.0147	CbGpPWpGaD
Acamprosate—Feeling abnormal—Methotrexate—germ cell cancer	0.000383	0.000749	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000382	0.0146	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00038	0.000744	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—ALPL—germ cell cancer	0.000377	0.0144	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000375	0.0143	CbGpPWpGaD
Acamprosate—Urticaria—Methotrexate—germ cell cancer	0.000369	0.000723	CcSEcCtD
Acamprosate—Body temperature increased—Methotrexate—germ cell cancer	0.000367	0.000719	CcSEcCtD
Acamprosate—Abdominal pain—Methotrexate—germ cell cancer	0.000367	0.000719	CcSEcCtD
Acamprosate—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—germ cell cancer	0.000359	0.0137	CbGpPWpGaD
Acamprosate—GRIN2D—CREB phosphorylation through the activation of Ras—HRAS—germ cell cancer	0.000357	0.0137	CbGpPWpGaD
Acamprosate—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—germ cell cancer	0.00035	0.0134	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TDGF1—germ cell cancer	0.000342	0.0131	CbGpPWpGaD
Acamprosate—Hypersensitivity—Methotrexate—germ cell cancer	0.000342	0.00067	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—TDGF1—germ cell cancer	0.000334	0.0128	CbGpPWpGaD
Acamprosate—Asthenia—Methotrexate—germ cell cancer	0.000333	0.000653	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—OXT—germ cell cancer	0.00033	0.0126	CbGpPWpGaD
Acamprosate—Pruritus—Methotrexate—germ cell cancer	0.000329	0.000643	CcSEcCtD
Acamprosate—Diarrhoea—Methotrexate—germ cell cancer	0.000318	0.000622	CcSEcCtD
Acamprosate—GRIN2C—Post NMDA receptor activation events—HRAS—germ cell cancer	0.000316	0.0121	CbGpPWpGaD
Acamprosate—Dizziness—Methotrexate—germ cell cancer	0.000307	0.000601	CcSEcCtD
Acamprosate—Vomiting—Methotrexate—germ cell cancer	0.000295	0.000578	CcSEcCtD
Acamprosate—GRIN2D—Post NMDA receptor activation events—HRAS—germ cell cancer	0.000294	0.0112	CbGpPWpGaD
Acamprosate—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—germ cell cancer	0.000293	0.0112	CbGpPWpGaD
Acamprosate—Rash—Methotrexate—germ cell cancer	0.000293	0.000573	CcSEcCtD
Acamprosate—Dermatitis—Methotrexate—germ cell cancer	0.000293	0.000573	CcSEcCtD
Acamprosate—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—germ cell cancer	0.000291	0.0111	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SALL4—germ cell cancer	0.000291	0.0111	CbGpPWpGaD
Acamprosate—Headache—Methotrexate—germ cell cancer	0.000291	0.00057	CcSEcCtD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000288	0.011	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—SALL4—germ cell cancer	0.000284	0.0108	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000283	0.0108	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NANOG—germ cell cancer	0.000279	0.0107	CbGpPWpGaD
Acamprosate—Nausea—Methotrexate—germ cell cancer	0.000276	0.00054	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—NANOG—germ cell cancer	0.000272	0.0104	CbGpPWpGaD
Acamprosate—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—germ cell cancer	0.000271	0.0104	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—POU5F1—germ cell cancer	0.000269	0.0103	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—POU5F1—germ cell cancer	0.000262	0.01	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000261	0.00998	CbGpPWpGaD
Acamprosate—GRIN1—CREB phosphorylation through the activation of Ras—HRAS—germ cell cancer	0.000256	0.00978	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—ALPL—germ cell cancer	0.000255	0.00975	CbGpPWpGaD
Acamprosate—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—germ cell cancer	0.00025	0.00953	CbGpPWpGaD
Acamprosate—GRIN2A—Post NMDA receptor activation events—HRAS—germ cell cancer	0.000242	0.00923	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—AVP—germ cell cancer	0.000226	0.00864	CbGpPWpGaD
Acamprosate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—germ cell cancer	0.000222	0.0085	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000221	0.00844	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000212	0.00811	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KLF4—germ cell cancer	0.000211	0.00808	CbGpPWpGaD
Acamprosate—GRIN1—Post NMDA receptor activation events—HRAS—germ cell cancer	0.000211	0.00805	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KLF4—germ cell cancer	0.000206	0.00788	CbGpPWpGaD
Acamprosate—GRIN2B—Post NMDA receptor activation events—HRAS—germ cell cancer	0.000205	0.00785	CbGpPWpGaD
Acamprosate—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—germ cell cancer	0.000194	0.00741	CbGpPWpGaD
Acamprosate—GRIN1—EPHB-mediated forward signaling—HRAS—germ cell cancer	0.000194	0.00741	CbGpPWpGaD
Acamprosate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—germ cell cancer	0.000189	0.00723	CbGpPWpGaD
Acamprosate—GRIN2B—EPHB-mediated forward signaling—HRAS—germ cell cancer	0.000189	0.00723	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—OXT—germ cell cancer	0.000186	0.00713	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—TP53—germ cell cancer	0.00018	0.00689	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—OXT—germ cell cancer	0.000169	0.00647	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—TP53—germ cell cancer	0.000168	0.0064	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000163	0.00623	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00016	0.00612	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SOX2—germ cell cancer	0.000149	0.00569	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—SOX2—germ cell cancer	0.000145	0.00555	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00014	0.00535	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TP53—germ cell cancer	0.000138	0.00526	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000133	0.00507	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AVP—germ cell cancer	0.000128	0.00488	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000125	0.00478	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	0.000121	0.00462	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TP53—germ cell cancer	0.00012	0.00459	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TP53—germ cell cancer	0.000117	0.00447	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AVP—germ cell cancer	0.000116	0.00443	CbGpPWpGaD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	0.000109	0.00417	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000107	0.00408	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MYC—germ cell cancer	0.000106	0.00405	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000105	0.00401	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000105	0.004	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000103	0.00394	CbGpPWpGaD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	0.000101	0.00388	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—OXT—germ cell cancer	0.0001	0.00382	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—HRAS—germ cell cancer	9.99e-05	0.00382	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—HRAS—germ cell cancer	9.74e-05	0.00372	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	9.16e-05	0.0035	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	9.02e-05	0.00345	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TP53—germ cell cancer	8.71e-05	0.00333	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGF4—germ cell cancer	8.54e-05	0.00326	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	8.33e-05	0.00318	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—HRAS—germ cell cancer	8.2e-05	0.00313	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—H2AFZ—germ cell cancer	7.63e-05	0.00291	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—HRAS—germ cell cancer	7.62e-05	0.00291	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	7.27e-05	0.00278	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—HRAS—germ cell cancer	7.1e-05	0.00271	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	7.08e-05	0.00271	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KITLG—germ cell cancer	7.01e-05	0.00268	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—HRAS—germ cell cancer	6.92e-05	0.00265	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AVP—germ cell cancer	6.86e-05	0.00262	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—HRAS—germ cell cancer	6.28e-05	0.0024	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—HRAS—germ cell cancer	6.26e-05	0.00239	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—HRAS—germ cell cancer	5.84e-05	0.00223	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—HRAS—germ cell cancer	5.46e-05	0.00209	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—HRAS—germ cell cancer	5.32e-05	0.00203	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGFR3—germ cell cancer	5.21e-05	0.00199	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—AVP—germ cell cancer	4.92e-05	0.00188	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—AVP—germ cell cancer	4.83e-05	0.00185	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—HRAS—germ cell cancer	4.8e-05	0.00183	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	4.79e-05	0.00183	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KIT—germ cell cancer	4.79e-05	0.00183	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	4.71e-05	0.0018	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—HRAS—germ cell cancer	4.69e-05	0.00179	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—AVP—germ cell cancer	4.22e-05	0.00161	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—HRAS—germ cell cancer	4.18e-05	0.0016	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	4.11e-05	0.00157	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—HRAS—germ cell cancer	4.08e-05	0.00156	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—HRAS—germ cell cancer	3.71e-05	0.00142	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—HRAS—germ cell cancer	3.62e-05	0.00138	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—HRAS—germ cell cancer	3.6e-05	0.00138	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—HRAS—germ cell cancer	3.54e-05	0.00135	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HRAS—germ cell cancer	3.5e-05	0.00134	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—HRAS—germ cell cancer	3.09e-05	0.00118	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—HRAS—germ cell cancer	2.76e-05	0.00105	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—HRAS—germ cell cancer	2.71e-05	0.00104	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HRAS—germ cell cancer	2.65e-05	0.00101	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—germ cell cancer	2.63e-05	0.00101	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HRAS—germ cell cancer	2.58e-05	0.000987	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—HRAS—germ cell cancer	2.37e-05	0.000905	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—germ cell cancer	2.16e-05	0.000826	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HRAS—germ cell cancer	2.07e-05	0.00079	CbGpPWpGaD
